This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: F. Hoffmann-La Roche Ag, Prothena Biosciences Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 181 
1 out of 64 
Years Active: 2026
Title: Frank Boess: Innovator in Synucleinopathies Treatment
Introduction
Frank Boess is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of synucleinopathies. His innovative work has led to the development of a patent that addresses critical aspects of dosing regimens for these conditions.
Latest Patents
Frank Boess holds a patent titled "Dosing Regimes for Treatment of Synucleinopathies." This patent represents his commitment to advancing medical treatments and improving patient outcomes. He has 1 patent to his name, showcasing his innovative approach to addressing complex medical challenges.
Career Highlights
Throughout his career, Frank Boess has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with F. Hoffmann-La Roche AG and Prothena Biosciences Limited. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research.
Collaborations
Frank Boess has collaborated with talented individuals in his field, including Jay Soto and Daniel Keith Ness. These partnerships have enriched his work and fostered an environment of innovation and creativity.
Conclusion
Frank Boess is a distinguished inventor whose work in the treatment of synucleinopathies has made a significant impact in the medical field. His patent and collaborations reflect his dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile